Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
22.23
-0.27 (-1.20%)
At close: Dec 26, 2025, 4:00 PM EST
22.21
-0.02 (-0.09%)
After-hours: Dec 26, 2025, 6:45 PM EST
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $15.46 billion as of December 26, 2025. Its market cap has increased by 73.80% in one year.
Market Cap
15.46B
Enterprise Value
11.17B
1-Year Change
73.80%
Ranking
Category
Stock Price
$22.23
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $15.46B, an increase of 2,798.66%. That is a compound annual growth rate of 94.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 15.65B | 81.71% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |